GO
Loading...

Pfizer Inc

More

  • LONDON, July 30- AstraZeneca took a major step to build up its respiratory medicine business on Wednesday by striking a deal worth up to $2.1 billion to acquire the rights to lung drugs developed by Spain's Almirall.

  • LONDON, July 30- AstraZeneca took a major step to build up its respiratory medicine business on Wednesday by striking a deal worth up to $2.1 billion to acquire the rights to lung drugs developed by Spain's Almirall.

  • *Merck up as results beat expectations, but Pfizer slips. United Parcel Service shares fell 3.7 percent to $98.86 after the world's biggest courier company slashed its earnings forecast for the year due to spending to boost capacity. Rival shipping company FedEx Corp was down 1.6 percent at $147.14.

  • *Merck up as results beat expectations, but Pfizer slips. United Parcel Service shares fell 3.1 percent to $99.47 after the world's biggest courier company slashed its earnings forecast for the year due to spending to boost capacity. Rival shipping company FedEx Corp was down 0.8 percent at $148.36.

  • AP Top Financial News At 2:15 p.m. EDT Tuesday, 29 Jul 2014 | 2:15 PM ET

    Fed is weighing key issues but may reveal little Stocks inch up ahead of economic data US consumer confidence jumps to 90.9 in July Avoiding plane crashes as air traffic doubles Sources: EU adopts tough new sanctions on Russia Study: 35 percent in US facing debt collectors UBS sees profits rise, probed over trading system China investigating Microsoft in monopoly case US home price gains slow for 6th straight month Pfizer's 2 Q profit sinks 79 pct but tops forecasts

  • July 29- Pfizer Inc, which in May abandoned its $118 billion bid to buy AstraZeneca Plc, on Tuesday left investors guessing whether it would renew its pursuit of its British rival, but said it was considering other deals. Under UK takeover rules, AstraZeneca can attempt to re-engage with Pfizer in August, and Pfizer can make another run at AstraZeneca in November.

  • *Merck rises as results beat expectations, but Pfizer slips. Windstream Holdings jumped 12.8 percent to $11.88 in its busiest trading day on record after the company filed to spin off assets into a tax-efficient publicly-traded real estate investment trust.

  • *Wall St little changed as industrials, techs weigh; telecoms gain. NEW YORK, July 29- World share markets hovered just below all-time highs on Tuesday as investors drew encouragement from a rally in China, while Russian stocks enjoyed some respite after three days of heavy selling.

  • *Pfizer, Merck rise as results beat expectations. NEW YORK, July 29- U.S. stocks rose Tuesday on news about a spinoff in the telecommunications sphere that sent most stocks in the sector soaring and on better-than-expected results from Pfizer and Merck.

  • Pfizer beats forecasts as oncology drugs grow Tuesday, 29 Jul 2014 | 10:54 AM ET

    Pfizer reported higher-than-expected second-quarter earnings, helped by growing sales of its cancer medicines.

  • Merck beats forecasts, as newer drugs offset generics Tuesday, 29 Jul 2014 | 10:39 AM ET
    Merck employees walk past a Merck sign in front of the company's building in Summit, New Jersey.

    Merck reported better-than-expected quarterly results, with sales of newer drugs mostly offsetting declining sales of drugs facing generic competition.

  • July 29- Merck& Co Inc reported better-than-expected quarterly results on Tuesday, helped by strong sales of consumer products and medicines for arthritis and HIV, sending its shares up more than 1 percent in morning trading.

  • Merck & Pfizer beat the Street     Tuesday, 29 Jul 2014 | 10:14 AM ET

    CNBC's Meg Tirrell reports both Merck and Pfizer beat earnings expectations amid patent expirations.

  • NEW YORK, July 29- U.S. stocks rose slightly at the open on Tuesday following better-than-expected results from companies such as Pfizer and Merck and ahead of data on consumer sentiment.

  • US STOCKS-Wall St to rise on earnings, data weighs Tuesday, 29 Jul 2014 | 9:16 AM ET

    *Pfizer, Merck rise as results beat expectations. NEW YORK, July 29- U.S. stocks were set to rise slightly at the open on Tuesday following better-than-expected results from companies such as Pfizer and Merck and ahead of data on consumer sentiment. Pfizer's higher-than-expected second-quarter earnings were helped by growing sales of its cancer medicines.

  • Cramer: Stay long Merck     Tuesday, 29 Jul 2014 | 9:06 AM ET

    The "Squawk on the Street" news team discusses the quarterly results of Merck and Pfizer.

  • Stock futures further their rise on home-price data Tuesday, 29 Jul 2014 | 9:05 AM ET

    U.S. stock-index futures rose Tuesday as investors looked to economic reports, earnings and the Fed's mid-week policy decision.

  • 'This bull market has more legs': Pro Tuesday, 29 Jul 2014 | 8:53 AM ET

    Stronger earnings for the second quarter and beyond will be the key driver that keeps gas in the bull market gas tank, leading quantitative strategists tell CNBC.

  • How banks are cashing in on tax-evading mergers Tuesday, 29 Jul 2014 | 8:29 AM ET
    Jamie Dimon

    Investment banks have collected, or will soon collect, $1B in fees to help American companies "move" abroad. NYT reports.

  • Big pharma tax attack     Tuesday, 29 Jul 2014 | 8:04 AM ET

    Fundamentally, U.S.-based companies are at a disadvantage because of our tax code, says Barbara Ryan, FTI Consulting, sharing her thoughts on tax inversion among the big pharma space.